Quantcast

2009 Great Year for Emergency Preparedness Business

December 30, 2009

MOORESVILLE, N.C., Dec. 30 /PRNewswire/ — For Nukepills.com, specialists in the niche market of radiation emergency preparedness, 2009 was a year of record sales due to events such as Iran’s nuclear program, nuclear plant radiation leaks, Potassium Iodide distribution programs and worries of dirty bombs. Even the Swine Flu pandemic played a role in the surge of sales.

In early 2009, Nukepills.com delivered 5.4 million doses of FDA-approved ThyroShield Potassium Iodide to Kuwait’s Ministry of Health to protect its citizens from nuclear radiation. Kuwaiti officials said the threat of a U.S. attack on Iran’s nuclear reactor prompted the purchase. This sale was featured in a news story titled “Local company sells millions of ‘Nukepills’ to Kuwait” by a Charlotte NBC affiliate and was viewed nationwide.

This past fall a very limited supply of potassium iodide tablets was distributed courtesy of the U.S. Government to people residing within 10 miles of select nuclear plants. Due to this token handout consumer retail orders of Iosat(TM) Potassium Iodide increased by almost 400% and wholesale orders to nuclear and medical facilities surged as well for the authorized international distributor. Massachusetts Representative Edward Markey has since sent a letter to President Obama asking for a review of the much larger potassium iodide distribution program dropped by the Bush administration in 2007.

Numerous 2009 reports of radiation leaks at multiple nuclear plants, including Pennsylvania’s Three Mile Island, spawned even more sales of the radiation-blocking drug potassium iodide. Most online orders were from civilians not wanting to rely solely on the government for help in the event of a nuclear accident or terrorist attack. Many believe the slow process of evacuation would not alone protect them. National Public Radio (NPR) did a Thanksgiving Day feature story on Nukepills.com titled “Nuclear Radiation Worries? There’s A Pill For That.” This nationally broadcast NPR story raised additional awareness of the dire need for the stockpiling of potassium iodide in U.S. homes and dramatically boosted sales of the radiation drug.

Worries of a planned dirty bomb attack on New York City’s transit system prompted orders of the Dirty Bomb Emergency Kit by civilians and heath officials in New York and other major cities. The kit includes the RADTriage Radiation Detector tested and approved by the U.S. Department of Homeland Security.

The 2009 Swine Flu pandemic unexpectedly boosted the bottom line for Nukepills.com as well. In response to media stories of the Swine Flu Virus (H1N1), the company’s large inventory of N95 face masks, normally purchased online for protection during radiation decontamination, was depleted in just a few days. Nukepills.com quickly restocked and quadrupled its inventory of N95 masks to cover its wholesale and retail business for the remainder of the year. Again, those masks were quickly snatched up by hospitals, retirement homes and individuals to protect against the flu.

Nukepills.com, celebrating its 10th year in business, is an Internet-based supplier of radiation emergency preparedness products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation detection, radiation therapy and decontamination in hospitals. Nukepills.com is the world’s largest retailer of potassium iodide and sells to the general public, nuclear facilities, hospitals and federal, state and local governments (including the Nuclear Regulatory Commission and U.S. Department of Homeland Security). Nukepills.com now has international sales programs throughout North America, Europe, Asia and the Middle East.

Photos:

http://www.ereleases.com/pr/Nukepills.jpg

http://www.ereleases.com/pr/Nukepills-2.jpg


    Contact Information:

    Troy Jones
    President
    Nukepills.com
    631 Brawley School Rd STE 407
    Mooresville, NC 28117
    Phone: 866-283-3986
    Email: info@nukepills.com
    Website: http://www.nukepills.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Nukepills.com


Source: newswire



comments powered by Disqus